283 related articles for article (PubMed ID: 22090275)
1. LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.
Haase CL; Tybjærg-Hansen A; Qayyum AA; Schou J; Nordestgaard BG; Frikke-Schmidt R
J Clin Endocrinol Metab; 2012 Feb; 97(2):E248-56. PubMed ID: 22090275
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
Wittrup HH; Andersen RV; Tybjaerg-Hansen A; Jensen GB; Nordestgaard BG
J Clin Endocrinol Metab; 2006 Apr; 91(4):1438-45. PubMed ID: 16418216
[TBL] [Abstract][Full Text] [Related]
3. Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.
Johannsen TH; Kamstrup PR; Andersen RV; Jensen GB; Sillesen H; Tybjaerg-Hansen A; Nordestgaard BG
J Clin Endocrinol Metab; 2009 Apr; 94(4):1264-73. PubMed ID: 19088157
[TBL] [Abstract][Full Text] [Related]
4. Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease.
Haase CL; Tybjærg-Hansen A; Grande P; Frikke-Schmidt R
J Clin Endocrinol Metab; 2010 Dec; 95(12):E500-10. PubMed ID: 20826588
[TBL] [Abstract][Full Text] [Related]
5. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.
Frikke-Schmidt R; Nordestgaard BG; Stene MC; Sethi AA; Remaley AT; Schnohr P; Grande P; Tybjaerg-Hansen A
JAMA; 2008 Jun; 299(21):2524-32. PubMed ID: 18523221
[TBL] [Abstract][Full Text] [Related]
6. Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study.
Benn M; Tybjaerg-Hansen A; McCarthy MI; Jensen GB; Grande P; Nordestgaard BG
J Am Coll Cardiol; 2012 Jun; 59(25):2356-65. PubMed ID: 22698489
[TBL] [Abstract][Full Text] [Related]
7. Identification of genetic variants of lecithin cholesterol acyltransferase in individuals with high HDL‑C levels.
Naseri M; Hedayati M; Daneshpour MS; Bandarian F; Azizi F
Mol Med Rep; 2014 Jul; 10(1):496-502. PubMed ID: 24789697
[TBL] [Abstract][Full Text] [Related]
8. Milk intake is not associated with ischaemic heart disease in observational or Mendelian randomization analyses in 98,529 Danish adults.
Bergholdt HK; Nordestgaard BG; Varbo A; Ellervik C
Int J Epidemiol; 2015 Apr; 44(2):587-603. PubMed ID: 26085675
[TBL] [Abstract][Full Text] [Related]
9. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.
Jørgensen AB; Frikke-Schmidt R; West AS; Grande P; Nordestgaard BG; Tybjærg-Hansen A
Eur Heart J; 2013 Jun; 34(24):1826-33. PubMed ID: 23248205
[TBL] [Abstract][Full Text] [Related]
10. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.
Benn M; Nordestgaard BG; Grande P; Schnohr P; Tybjaerg-Hansen A
J Am Coll Cardiol; 2010 Jun; 55(25):2833-42. PubMed ID: 20579540
[TBL] [Abstract][Full Text] [Related]
11. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
[TBL] [Abstract][Full Text] [Related]
12. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study.
Brøndum-Jacobsen P; Benn M; Afzal S; Nordestgaard BG
Int J Epidemiol; 2015 Apr; 44(2):651-61. PubMed ID: 25981321
[TBL] [Abstract][Full Text] [Related]
13. High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol.
Dullaart RP; Perton F; van der Klauw MM; Hillege HL; Sluiter WJ;
Atherosclerosis; 2010 Feb; 208(2):537-42. PubMed ID: 19698944
[TBL] [Abstract][Full Text] [Related]
14. HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study.
Haase CL; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R
Diabetes; 2015 Sep; 64(9):3328-33. PubMed ID: 25972569
[TBL] [Abstract][Full Text] [Related]
15. Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis.
Stender S; Frikke-Schmidt R; Nordestgaard BG; Grande P; Tybjaerg-Hansen A
J Intern Med; 2013 Jan; 273(1):59-68. PubMed ID: 22805420
[TBL] [Abstract][Full Text] [Related]
16. Effects of lecithin: cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels.
Agirbasli D; Cirakoglu B; Eren F; Sumerkan M; Aksoy S; Aral C; Agirbasli M
J Clin Lipidol; 2011; 5(3):152-158. PubMed ID: 21600519
[TBL] [Abstract][Full Text] [Related]
17. Premature and severe cardiovascular disease in a Mexican male with markedly low high-density-lipoprotein-cholesterol levels and a mutation in the lecithin:cholesterol acyltransferase gene: a family study.
Posadas-Sánchez R; Posadas-Romero C; Ocampo-Arcos WA; Villarreal-Molina MT; Vargas-Alarcón G; Antúnez-Argüelles E; Mendoza-Pérez E; Cardoso-Saldaña G; Martínez-Alvarado R; Medina-Urrutia A; Jorge-Galarza E
Int J Mol Med; 2014 Jun; 33(6):1570-6. PubMed ID: 24715031
[TBL] [Abstract][Full Text] [Related]
18. Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: implications for cardiac outcome.
Dullaart RP; Tietge UJ; Kwakernaak AJ; Dikkeschei BD; Perton F; Tio RA
Atherosclerosis; 2014 May; 234(1):185-92. PubMed ID: 24661908
[TBL] [Abstract][Full Text] [Related]
19. Remnant cholesterol as a causal risk factor for ischemic heart disease.
Varbo A; Benn M; Tybjærg-Hansen A; Jørgensen AB; Frikke-Schmidt R; Nordestgaard BG
J Am Coll Cardiol; 2013 Jan; 61(4):427-436. PubMed ID: 23265341
[TBL] [Abstract][Full Text] [Related]
20. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
